Loading TeyzSec
Securing your experience...
Securing your experience...
Accelerate multi-site clinical trial analysis while maintaining regulatory compliance and data privacy.
Multi-site clinical trials require coordinating patient data across research sites in different countries and regulatory jurisdictions. Data sharing is slow due to HIPAA, GDPR, and local privacy laws. Analysis lags while lawyers negotiate data-sharing agreements.
Each trial site trains a model on its patient cohort locally. Models are aggregated securely without raw data moving. Trial-level insights are shared, but individual patient records stay at the originating site.
Trial sites across 5 countries train local models on their patient subsets (different demographics, genetics, comorbidities).
Model updates are encrypted and sent to a central aggregator (can be the sponsor or a neutral third party).
Global model is trained 10x faster because all sites contribute simultaneously without sharing raw data.
Trial sponsors get aggregated results and can adjust protocols in real-time.
No data leaves national boundaries. GDPR, HIPAA, and local regulations are satisfied because data stays put. Faster trial cycles = faster drug approvals.
Data stays within regulatory boundaries. No cross-border data transfer agreements needed. Satisfies GDPR, HIPAA, and local privacy laws simultaneously.
Eliminate data-sharing bottlenecks. Aggregate results in weeks instead of months. Get to trial completion faster.
Models trained on diverse patient cohorts across continents. Better understanding of drug efficacy across populations.
Document exactly which sites contributed, when, and for how long. Regulatory audits are straightforward.